Cite
MLA Citation
Marc-Andrea Baertsch et al.. “Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma.” BMC cancer, vol. 16, no. 1, 2016, pp. 1–10. http://access.bl.uk/ark:/81055/vdc_100080452790.0x000165